SCTV01E: Clinical Trials

3 trials of SCTV01E, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3

Follow SCTV01E: new trials by email Literature Review of SCTV01E trials Research Report on SCTV01E

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People
CoronaVac, SCTV01E - COVID-19 SARS-CoV-2 Infection
Phase 3UnknownSinocelltech Ltd.60002023-01-252023-01-13
A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years
SCTV01E, Placebo - COVID-19, SARS-CoV-2 Infection
Phase 3UnknownSinocelltech Ltd.100002022-12-262024-04-15
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines
SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine - COVID-19, SARS-CoV-2 Infection
Phase 3UnknownSinocelltech Ltd.18002022-05-302023-04-10

Conditions studied

COVID-19 (2)

Sponsors

Sinocelltech Ltd. (3)

Countries

China (1)  ·  United Arab Emirates (1)

Top investigators

Yu Sun (1)

Results publications

PMID 36598621, PMID 37731938, PMID 41012186